A PYMNTS Company

US: Wright Medical Group, Tornier $3.3 billion merger approved

By  |  September 30, 2015

Wright Medical Group and Tornier NV have won U.S. antitrust approval for their merger on condition that they sell certain assets related to replacement ankle and toe joints, the Federal Trade Commission said on Wednesday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The companies said when the deal was announced in October 2014 that the proposed transaction would create a company with a combined value of about $3.3 billion.

    The deal will be allowed to go ahead on condition that the companies sell Tornier’s U.S. rights and assets related to total ankle replacements and total silastic toe joint replacements used to treat arthritis, the FTC said.

    The FTC said that it required the divestitures because Wright has 44 percent of the market for the ankle replacements and Tornier has about 19 percent. They also have big shares of the market to make silastic toe joint replacements, the FTC said.

    Full content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.